Tero Aittokallio

What is synergy? The Saariselka agreement revisited (2015)

Frontiers in Pharmacology

Tang J, Wennerberg K, Aittokallio T

(Vertaisarvioitu katsausartikkeli tieteellisessä aikakauslehdessä (A2))

Toward more realistic drug-target interaction predictions (2015)

Briefings in Bioinformatics

Tapio Pahikkala, Antti Airola, Sami Pietilä, Sushil Shakyawar, Agnieszka Szwajda, Jing Tang, Tero Aittokallio

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Patient-derived prostate cancer cells for piloting of drug sensitivity and resistance testing (2015)

BJU International

Saeed K, Rahkama V, Eldfors S, Bychkov D, Mpindi JP, Yadav B, Paavolainen L, Aittokallio T, Wennerberg K, Peehl DM, Horvath P, Mirtti T, Rannikko A, Kallioniemi O, Ostling P, af Hallstrom TM

(O2 Muu julkaisu )

Pro-apoptotic functions of AMPK revealed by Myc (2015)

Molecular Cancer Research

Haikala HM, Marques E, Eskelinen V, Viheriaranta-Nieminen A, Saarikoski S, Nevalaita L, Kovanen P, Heikkila P, Leidenius M, Laajala D, Aittokallio T, Munne P, Klefstrom J

(O2 Muu julkaisu )

TIMMA-R: an R package for predicting synergistic multi-targeted drug combinations in cancer cell lines or patient-derived samples (2015)

Bioinformatics

He LY, Wennerberg K, Aittokallio T, Tang J

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

High-throughput drug sensitivity and resistance testing of ovarian cancer cell lines provides useful strategy for assessing drug repositioning and therapeutic possibilities of emerging drugs (2015)

Clinical Cancer Research

Hirasawa A, Murumagi A, Arjama M, Yadav B, Mpindi JP, Wennerberg K, Aittokallio T, Aoki D, Kallioniemi O

(O2 Muu julkaisu )

Impact of normalization methods on high-throughput screening data with high hit rates and drug testing with dose-response data (2015)

Bioinformatics

Mpindi JP, Swapnil P, Dmitrii B, Jani S, Saeed K, Wennerberg K, Aittokallio T, Ostling P, Kallioniemi O

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Prediction of human population responses to toxic compounds by a collaborative competition (vol 33, pg 933, 2015) (2015)

Nature Biotechnology

Eduati F, Mangravite LM, Wang T, Tang H, Bare JC, Huang RL, Norman T, Kellen M, Menden MP, Yang JC, Zhang X, Zhong R, Xiao GH, Xia MH, Abdo N, Kosyk O, Friend S, Dearry A, Simeonov A, Tice RR, Rusyn I, Wright FA, Stolovitzky G, Xie Y, Saez-Rodriguez J, Jaiswal A, Poso A, Chheda H, Kaur I, Tang J, Mpindi JP, Wennerberg K, Krasnogor N, Kaski S, Aittokallio T, Hintsanen P, Khan SA

(O2 Muu julkaisu )

Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies (2014)

Scientific Reports

Yadav B, Pemovska T, Szwajda A, Kulesskiy E, Kontro M, Karjalainen R, Majumder MM, Malani D, Murumagi A, Knowles J, Porkka K, Heckman C, Kallioniemi O, Wennerberg K, Aittokallio T

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Network Pharmacology Strategies Toward Multi-Target Anticancer Therapies: From Computational Models to Experimental Design Principles (2014)

Current Pharmaceutical Design

Tang J, Aittokallio T

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Ota yhteyttä

Linkit

Julkaisut

Järjestä:

What is synergy? The Saariselka agreement revisited (2015)

Toward more realistic drug-target interaction predictions (2015)

Patient-derived prostate cancer cells for piloting of drug sensitivity and resistance testing (2015)

Pro-apoptotic functions of AMPK revealed by Myc (2015)

TIMMA-R: an R package for predicting synergistic multi-targeted drug combinations in cancer cell lines or patient-derived samples (2015)

High-throughput drug sensitivity and resistance testing of ovarian cancer cell lines provides useful strategy for assessing drug repositioning and therapeutic possibilities of emerging drugs (2015)

Impact of normalization methods on high-throughput screening data with high hit rates and drug testing with dose-response data (2015)

Prediction of human population responses to toxic compounds by a collaborative competition (vol 33, pg 933, 2015) (2015)

Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies (2014)

Network Pharmacology Strategies Toward Multi-Target Anticancer Therapies: From Computational Models to Experimental Design Principles (2014)